Skip to content

Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section

Effect of OPRM1 Genotype on the Dose Response to Spinal Morphine for Post-Cesarean Analgesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01465191
Enrollment
169
Registered
2011-11-04
Start date
2011-11-30
Completion date
2014-05-31
Last updated
2020-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

cesarean, postoperative, morphine, genetics, opioid

Brief summary

HYPOTHESIS: The response to a given dose of morphine given via a spinal anesthetic for cesarean section will be affected by the genetics of the woman's mu-opioid receptor Most women undergoing elective cesarean section (CS) receive spinal anesthesia, and most receive a dose of preservative free morphine with the spinal anesthetic. Spinally-administered morphine provides 16-24 hours of high quality pain relief. The dose administered is usually 75-200 micrograms, but surprisingly few dose-response studies exist. The mu-opioid receptor (OPRM1 gene)is the site of action of endogenous opioid peptides and opioid analgesic drugs like morphine. There is a common genetic variant of this receptor at the 40th amino acid of the protein, with asparagine and asparate being present in different people. The less common variant (aspartate), present in 25-30% of the overall American population (higher in Asian populations, lower in Blacks) at codon 40 that has been shown in many studies to affect opioid analgesia. This will be a randomized, blinded study of 3 doses of spinal morphine (50, 100, 150 micrograms) given to women undergoing elective cesarean section at term pregnancy. 300 women will be studied (100 per dose). Blood will be obtained for genotyping of OPRM1 and other genes that may affect pain and analgesic responses. The primary outcome will be the amount of intravenous morphine patients self-administer in the 24 hours postsurgery. The primary outcome (use of intravenous morphine) will be analyzed by dose, and within each dose group by genotype of OPRM1. Secondary outcomes will include pain scores every 6 hours, satisfaction with analgesia, side effects (itching, nausea/vomiting) by dose and genotype. It is anticipated that there will be an interim data analysis at 150 evaluable subjects for assessment of the dose response to morphine in the overall population; then a final analysis at 300 subjects for the genetic effect assessment.

Interventions

DRUGMorphine

Morphine will be given via spinal injection at doses of 50, 100, 150 micrograms as part of a spinal anesthetic for cesarean section

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* healthy women undergoing elective cesarean

Exclusion criteria

* cardiovascular disease * analgesic medications * complications of pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Milligrams of Intravenous Morphine Used by Participant in First 24 Hours Postoperatively24 hoursIV morphine use in milligrams, by participant-controlled analgesia will be assessed every 6 hours for 24 hours postoperatively.

Secondary

MeasureTime frameDescription
Visual Analog Scale (VAS) Pain at 12 Hours12 hours post-operativelyVisual analog pain scale measures pain on a 100 millimeter (mm) scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst pain imaginable (100mm). Pain measured at rest and with movement.
Visual Analog Scale (VAS) Pain at 18 Hours18 hours post-operativelyVisual analog pain scale measures pain on a 100 millimeter (mm) scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst pain imaginable (100mm). Pain measured at rest and with movement.
Visual Analog Scale (VAS) Pain at 24 Hours24 hours post-operativelyVisual analog pain scale measures pain on a 100 millimeter (mm) scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst pain imaginable (100mm). Pain measured at rest and with movement.
Visual Analog Scale- Nausea/Vomiting at 6 Hours6 hours post-operativelyVisual analog nausea/vomiting scale measures nausea and vomiting on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Nausea/Vomiting Imaginable (100mm).
Visual Analog Scale- Nausea/Vomiting at 12 Hours12 hours post-operativelyVisual analog nausea/vomiting scale measures nausea and vomiting on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Nausea/Vomiting Imaginable (100mm).
Visual Analog Scale- Nausea/Vomiting at 18 Hours18 hours post-operativelyVisual analog nausea/vomiting scale measures nausea and vomiting on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Nausea/Vomiting Imaginable (100mm).
Visual Analog Scale (VAS) Pain at 6 Hours6 hours post-operativelyVisual analog pain scale measures pain on a 100 millimeter (mm) scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst pain imaginable (100mm). Pain measured at rest and with movement.
Visual Analog Scale Pruritus (Itching) at 6 Hours6 hours post-operativelyVisual analog pruritus scale measures itching on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Itching Imaginable (100mm).
Visual Analog Scale Pruritus (Itching) at 12 Hours12 hours post-operativelyVisual analog pruritus scale measures itching on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Itching Imaginable (100mm).
Visual Analog Scale Pruritus (Itching) at 18 Hours18 hours post-operativelyVisual analog pruritus scale measures itching on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Itching Imaginable (100mm).
Visual Analog Scale Pruritus (Itching) at 24 Hours24 hours post-operativelyVisual analog pruritus scale measures itching on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Itching Imaginable (100mm).
Visual Analog Patient Satisfaction With Analgesia at 24 Hours24 hours postoperativelyVisual analog patient satisfaction scale measures satisfaction with analgesia on a 100mm scale. Participants make a mark on the scale with one end labeled Completely Dissatisfied (0mm) and the other labeled Completely Satisfied (100mm).
Visual Analog Scale- Nausea/Vomiting at 24 Hours24 hours post-operativelyVisual analog nausea/vomiting scale measures nausea and vomiting on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Nausea/Vomiting Imaginable (100mm).

Countries

United States

Participant flow

Participants by arm

ArmCount
50 Micrograms Spinal Morphine
these subjects will receive 50 mcg spinal morphine
47
100 Micrograms Spinal Morphine
these subjects will receive 100 mcg spinal morphine
54
150 Micrograms Spinal Morphine
these subjects will receive 150 mcg spinal morphine
43
Total144

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up364
Overall StudyProtocol Violation633

Baseline characteristics

Characteristic100 Micrograms Spinal Morphine150 Micrograms Spinal Morphine50 Micrograms Spinal MorphineTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
54 Participants43 Participants47 Participants144 Participants
Age, Continuous33 years
STANDARD_DEVIATION 5
33 years
STANDARD_DEVIATION 6
33 years
STANDARD_DEVIATION 6
33 years
STANDARD_DEVIATION 4
Region of Enrollment
United States
54 participants43 participants47 participants144 participants
Sex: Female, Male
Female
54 Participants43 Participants47 Participants144 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 470 / 540 / 43
other
Total, other adverse events
0 / 470 / 540 / 43
serious
Total, serious adverse events
0 / 470 / 540 / 43

Outcome results

Primary

Milligrams of Intravenous Morphine Used by Participant in First 24 Hours Postoperatively

IV morphine use in milligrams, by participant-controlled analgesia will be assessed every 6 hours for 24 hours postoperatively.

Time frame: 24 hours

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineMilligrams of Intravenous Morphine Used by Participant in First 24 Hours Postoperatively18 Milligrams
100 Micrograms Spinal MorphineMilligrams of Intravenous Morphine Used by Participant in First 24 Hours Postoperatively14 Milligrams
150 Micrograms Spinal MorphineMilligrams of Intravenous Morphine Used by Participant in First 24 Hours Postoperatively15 Milligrams
Secondary

Visual Analog Patient Satisfaction With Analgesia at 24 Hours

Visual analog patient satisfaction scale measures satisfaction with analgesia on a 100mm scale. Participants make a mark on the scale with one end labeled Completely Dissatisfied (0mm) and the other labeled Completely Satisfied (100mm).

Time frame: 24 hours postoperatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Patient Satisfaction With Analgesia at 24 Hours85 mm
100 Micrograms Spinal MorphineVisual Analog Patient Satisfaction With Analgesia at 24 Hours83 mm
150 Micrograms Spinal MorphineVisual Analog Patient Satisfaction With Analgesia at 24 Hours84 mm
Secondary

Visual Analog Scale- Nausea/Vomiting at 12 Hours

Visual analog nausea/vomiting scale measures nausea and vomiting on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Nausea/Vomiting Imaginable (100mm).

Time frame: 12 hours post-operatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 12 Hours0 mm
100 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 12 Hours0 mm
150 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 12 Hours0 mm
Secondary

Visual Analog Scale- Nausea/Vomiting at 18 Hours

Visual analog nausea/vomiting scale measures nausea and vomiting on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Nausea/Vomiting Imaginable (100mm).

Time frame: 18 hours post-operatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 18 Hours0 mm
100 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 18 Hours0 mm
150 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 18 Hours0 mm
Secondary

Visual Analog Scale- Nausea/Vomiting at 24 Hours

Visual analog nausea/vomiting scale measures nausea and vomiting on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Nausea/Vomiting Imaginable (100mm).

Time frame: 24 hours post-operatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 24 Hours0 mm
100 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 24 Hours0 mm
150 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 24 Hours0 mm
Secondary

Visual Analog Scale- Nausea/Vomiting at 6 Hours

Visual analog nausea/vomiting scale measures nausea and vomiting on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Nausea/Vomiting Imaginable (100mm).

Time frame: 6 hours post-operatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 6 Hours0 mm
100 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 6 Hours7 mm
150 Micrograms Spinal MorphineVisual Analog Scale- Nausea/Vomiting at 6 Hours0 mm
Secondary

Visual Analog Scale Pruritus (Itching) at 12 Hours

Visual analog pruritus scale measures itching on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Itching Imaginable (100mm).

Time frame: 12 hours post-operatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 12 Hours10 mm
100 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 12 Hours23 mm
150 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 12 Hours25 mm
Secondary

Visual Analog Scale Pruritus (Itching) at 18 Hours

Visual analog pruritus scale measures itching on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Itching Imaginable (100mm).

Time frame: 18 hours post-operatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 18 Hours9 mm
100 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 18 Hours13 mm
150 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 18 Hours5 mm
Secondary

Visual Analog Scale Pruritus (Itching) at 24 Hours

Visual analog pruritus scale measures itching on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Itching Imaginable (100mm).

Time frame: 24 hours post-operatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 24 Hours7 mm
100 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 24 Hours12 mm
150 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 24 Hours6 mm
Secondary

Visual Analog Scale Pruritus (Itching) at 6 Hours

Visual analog pruritus scale measures itching on a 100mm scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst Itching Imaginable (100mm).

Time frame: 6 hours post-operatively

ArmMeasureValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 6 Hours21 mm
100 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 6 Hours37 mm
150 Micrograms Spinal MorphineVisual Analog Scale Pruritus (Itching) at 6 Hours39 mm
Secondary

Visual Analog Scale (VAS) Pain at 12 Hours

Visual analog pain scale measures pain on a 100 millimeter (mm) scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst pain imaginable (100mm). Pain measured at rest and with movement.

Time frame: 12 hours post-operatively

ArmMeasureGroupValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 12 HoursRest20 mm
50 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 12 HoursMovement30 mm
100 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 12 HoursRest15 mm
100 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 12 HoursMovement35 mm
150 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 12 HoursRest10 mm
150 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 12 HoursMovement30 mm
Secondary

Visual Analog Scale (VAS) Pain at 18 Hours

Visual analog pain scale measures pain on a 100 millimeter (mm) scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst pain imaginable (100mm). Pain measured at rest and with movement.

Time frame: 18 hours post-operatively

ArmMeasureGroupValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 18 HoursRest17 mm
50 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 18 HoursMovement32 mm
100 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 18 HoursRest11 mm
100 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 18 HoursMovement30 mm
150 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 18 HoursRest5 mm
150 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 18 HoursMovement26 mm
Secondary

Visual Analog Scale (VAS) Pain at 24 Hours

Visual analog pain scale measures pain on a 100 millimeter (mm) scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst pain imaginable (100mm). Pain measured at rest and with movement.

Time frame: 24 hours post-operatively

ArmMeasureGroupValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 24 HoursRest24 mm
50 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 24 HoursMovement43 mm
100 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 24 HoursRest21 mm
100 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 24 HoursMovement41 mm
150 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 24 HoursRest18 mm
150 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 24 HoursMovement41 mm
Secondary

Visual Analog Scale (VAS) Pain at 6 Hours

Visual analog pain scale measures pain on a 100 millimeter (mm) scale. Participants make a mark on the scale with one end labeled None (0mm) and the other labeled Worst pain imaginable (100mm). Pain measured at rest and with movement.

Time frame: 6 hours post-operatively

ArmMeasureGroupValue (MEAN)
50 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 6 HoursRest20 mm
50 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 6 HoursMovement43 mm
100 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 6 HoursRest25 mm
100 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 6 HoursMovement43 mm
150 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 6 HoursRest15 mm
150 Micrograms Spinal MorphineVisual Analog Scale (VAS) Pain at 6 HoursMovement30 mm

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026